D.C.'s medical cannabis market is facing significant challenges, with fewer than 10% of conditional licenses for growers and manufacturers approved for locations, leading potential business owners like Bryan Jackson to abandon their plans. Despite the potential for over 70 new retail stores to open soon, the market is still grappling with low sales, which were reported to be the lowest in four years as of July 2024. The market's struggles are exacerbated by competition from unlicensed 'gifting' shops and Maryland's burgeoning adult-use cannabis market, which generated substantial revenue. Additionally, the opening of D.C.'s first licensed testing laboratory may help legitimize the program but has not yet translated into increased patient registrations or sales. The situation is dire enough that some medical dispensaries warn of imminent business failures without stronger enforcement against competition. As the market evolves, the D.C. government faces pressure to address these systemic issues to protect licensed operators and ensure the program's viability.